The Fiction of Social Security Bonds
How is Social Security different in kind from any other government program? Charles Rounds argues that it is not different at all.
U.S. Economy
Displaying 1631 - 1640 of 2063
That France Vote
The fallout from the French vote of “no” on the EU constitution includes a sign that Tony Blair may scrap plans to hold a similar refer
The New Deal in One Lesson
Chris Westley explains that the only thing new about New Deal policies was their name and the people administering them.
In Defense of Employment-at-Will
Opponents of employment-at-will speak of defending an employee's "individual freedom." Arthur Foulkes argues that this isn't freedom at all.
The Case for a 100 Percent Gold Dollar
Murray Rothbard, in this classic essay originally published in 1991, offers the most "pure" proposal of all: private mintage, 100 percent reserve banking, circulating coins, full convertibility.
The Issue of Tariffs: How U.S. Revenue Collection Was Turned Inside-Out
We went from tariffs being the major source of federal government revenue to what we have today under the income tax and payroll taxes. The time scope is from 1789 to the Great Depression. In 1790, 99.9% of federal government revenue is generated by tariffs – the first year we operate under the Constitution. In 1860, still 94% of total fed government revenue is generated by tariffs. Only the War Between the States changes this and we get our first federal income tax.
The Fair Tax Fraud
Although the FairTax would eliminate the filing of all individual tax returns, writes Laurence Vance, the FairTax turns every business into a tax collector.
Holding Hands
Blaming OPEC has been in political fashion for over three decades, writes Chris Westley.
Slaves to the Tax State
The rich find ways around the tax eaters, writes, Kirby Cundiff, by moving income and capital around and lobbying for loopholes.
Playing God at the FDA
What chain of events led to "free" Americans having less in the way of health choices under some circumstances than "unfree" socialist Europe? Dale Steinreich examines the FDA.
